Biotrial

Overview

Founded in 1989, Biotrial is a specialist CRO focused on drug development with over 35 years of experience conducting thousands of Phase I studies. The company operates as a full-service partner for biotechnology and pharmaceutical sponsors, offering comprehensive early-phase clinical programs from First-in-Human studies through Proof-of-Concept trials.

Clinical Infrastructure

Biotrial operates state-of-the-art Phase I clinical facilities strategically located near renowned university hospitals:

• Rennes, France: 150-bed facility
• New Jersey, USA: 110-bed facility
• Total capacity: 260 beds across both locations

Facilities include different-sized wards with high-care and telemetry beds designed for optimal patient care and safety in early-phase trials.

Core Services

• Early-phase clinical development (Phase I studies with healthy volunteers and special populations)
• Patient studies and Proof-of-Concept trials
• Bioanalysis and biometrics
• ECG monitoring
• CNS & imaging core lab services
• Clinical trial management, recruitment, regulatory compliance, and monitoring

Expertise & Capabilities

Biotrial's integrated project teams include clinical investigators, physicians, study nurses, data managers, statisticians, and clinical trial managers. The company emphasizes:

• Adherence to strict deadlines and operational flexibility
• High-quality standards and efficient trial management
• Tailor-made solutions for biotechnology and pharmaceutical sponsors
• Global collaboration capabilities across multiple countries